The DOI matches its Crossref record.
Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
Abstract
C3H/HeN mice that are naturally resistant to cutaneous disease and systemic infections with the protozoan parasite, Leishmania major, were treated at the time of infection, and weekly thereafter, with mouse anti-rat IFN-gamma mAb or an irrelevant antibody of similar isotype. Anti-IFN-gamma-treated mice developed cutaneous lesions; parasites spread to the regional lymph nodes and then metastasized to spleens and livers. The course of disease in these animals was similar to that of genetically susceptible BALB/c mice. Two exceptions in the pathology of L. major infections were noted between BALB/c and anti-IFN-gamma-treated C3H/HeN mice: 1) BALB/c mice died of systemic complications, whereas C3H/HeN mice did not, and 2) multinucleated giant cells were observed in lymph nodes and spleens of infected BALB/c mice, whereas these cells were not observed in infected C3H/HeN mice. Control mice, those treated with either saline or irrelevant antibody of the same isotype as the anti-IFN-gamma monoclonal, showed no evidence of cutaneous disease (development of footpad lesions) or systemic infection (by histopathology). Total abrogation of the natural resistance of C3H/HeN mice could be achieved by treatment with as little as 0.5 mg/mouse/wk of anti-IFN-gamma antibody, or by a single dose of 1 mg/mouse anti-IFN-gamma antibody administered at the time of parasite inoculation. If antibody treatment was delayed for as little as 1 wk after parasite inoculation, the infections in treated animals resembled that of untreated or control antibody-treated mice: no cutaneous lesions (by footpad swelling or viable counts of leishmania in footpad tissue) or systemic disease (by microscopic analysis of touch preparations of internal organs, and histopathology of same). The production of IFN-gamma during the initial interaction of the parasite and host cells appears to be a major component of genetic control of natural resistance to infection with L. major in C3H/HeN mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets
O'Garra, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80533-6 · Cited by 1,533
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
Recombinant interleukin 12 cures mice infected with Leishmania major.
Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., & Gately, M. K. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.5.1505 · Cited by 761
Hsieh, C. S., Heimberger, A. B., Gold, J. S., O'Garra, A., & Murphy, K. M. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.6065 · Cited by 747
Sypek, J. P., Chung, C. L., Mayor, S. E., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. F., & Schaub, R. G. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1797 · Cited by 720
Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S., & Locksley, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.115 · Cited by 620
Scharton, T. M., & Scott, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.567 · Cited by 608
Leishmaniases of the New World: current concepts and implications for future research
Grimaldi, G., & Tesh, R. B. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.3.230 · Cited by 597
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4
Mendiratta, S. K., Martin, W. D., Hong, S., Boesteanu, A., Joyce, S., & Van Kaer, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80290-3 · Cited by 595
Openshaw, P., Murphy, E. E., Hosken, N. A., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.5.1357 · Cited by 538
Heinzel, F. P., Sadick, M. D., Mutha, S. S., & Locksley, R. M. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7011 · Cited by 517
T cell genetic background determines default T helper phenotype development in vitro.
Hsieh, C. S., Macatonia, S. E., O'Garra, A., & Murphy, K. M. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.713 · Cited by 462
Laouar, Y., Sutterwala, F. S., Gorelik, L., & Flavell, R. A. (2005) · Nature Immunology · doi:10.1038/ni1197 · Cited by 451
Interleukin-18: A Novel Cytokine That Augments Both Innate and Acquired Immunity
(1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60389-2 · Cited by 450
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation.
Murphy, E., Shibuya, K., Hosken, N., Openshaw, P., Maino, V, Davis, K., Murphy, K., & O'Garra, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.901 · Cited by 435
Transforming Growth Factor-β in Leishmanial Infection: a Parasite Escape Mechanism
Barral-Netto, M., Barral, A., Brownell, C. E., Skeiky, Y. A. W., Ellingsworth, L. R., Twardzik, D. R., & Reed, S. G. (1992) · Science · doi:10.1126/science.1636092 · Cited by 434
Interferon-γ: Biology and Role in Pathogenesis
Billiau, A. (1996) · Advances in Immunology · doi:10.1016/s0065-2776(08)60428-9 · Cited by 433
An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis
Nicholson, L. B., Greer, J. M., Sobel, R. A., Lees, M. B., & Kuchroo, V. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90169-8 · Cited by 412
Cytokine regulation of T-cell function: potential for therapeutic intervention
Powrie, F., & Coffman, R. L. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90044-l · Cited by 408
Role of Cytokines and CD4+ T‐Cell Subsets in the Regulation of Parasite Immunity and Disease
Scott, P., Pearce, E., Cheever, A. W., Coffman, R. L., & Sher, A. (1989) · Immunological Reviews · doi:10.1111/j.1600-065x.1989.tb00557.x · Cited by 398
Role of cytokines in determining T-lymphocyte function
O'Garra, A., & Murphy, K. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90128-7 · Cited by 393
Wang, Z. E., Reiner, S. L., Zheng, S., Dalton, D. K., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1367 · Cited by 392
Genetic Susceptibility to Leishmania : IL-12 Responsiveness in T H 1 Cell Development
Güler, M. L., Gorham, J. D., Hsieh, C.-S., Mackey, A. J., Steen, R. G., Dietrich, W. F., & Murphy, K. M. (1996) · Science · doi:10.1126/science.271.5251.984 · Cited by 364
Reiner, S. L., Zheng, S., Wang, Z. E., Stowring, L., & Locksley, R. M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.447 · Cited by 363
Belkaid, Y., Mendez, S., Lira, R., Kadambi, N., Milon, G., & Sacks, D. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.969 · Cited by 363
Expression Cloning of a Protective Leishmania Antigen
Mougneau, E., Altare, F., Wakil, A. E., Zheng, S., Coppola, T., Wang, Z.-E., Waldmann, R., Locksley, R. M., & Glaichenhaus, N. (1995) · Science · doi:10.1126/science.7725103 · Cited by 345
Liew, F. Y., & O'Donnell, C. A. (1993) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60208-0 · Cited by 332
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
Stenger, S., Donhauser, N., Thüring, H., Röllinghoff, M., & Bogdan, C. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.4.1501 · Cited by 331
The Interaction of Leishmania Species with Macrophages
Alexander, J., & Russell, D. G. (1992) · Advances in Parasitology · doi:10.1016/s0065-308x(08)60022-6 · Cited by 323
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G., & Maliszewski, C. R. (1996) · Immunity · doi:10.1016/s1074-7613(00)80436-7 · Cited by 321
Carrera, L., Gazzinelli, R. T., Badolato, R., Hieny, S., Muller, W., Kuhn, R., & Sacks, D. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.2.515 · Cited by 315
Belkaid, Y., Von Stebut, E., Mendez, S., Lira, R., Caler, E., Bertholet, S., Udey, M. C., & Sacks, D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.8.3992 · Cited by 311
Ning, Q., Brown, D., Parodo, J., Cattral, M., Gorczynski, R., Cole, E., Fung, L., Ding, J. W., Liu, M. F., Rotstein, O., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3487 · Cited by 303
Stenger, S., Thüring, H., Röllinghoff, M., & Bogdan, C. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.3.783 · Cited by 302
Iwamoto, I., Nakajima, H., Endo, H., & Yoshida, S. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.2.573 · Cited by 302
Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., & Kikutani, H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80435-5 · Cited by 294
Bacterial DNA-Induced NK Cell IFN-γ Production Is Dependent on Macrophage Secretion of IL-12
Chace, J. H., Hooker, N. A., Mildenstein, K. L., Krieg, A. M., & Cowdery, J. S. (1997) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1997.4380 · Cited by 291
Schmitt, E., Hoehn, P., Huels, C., Goedert, S., Palm, N., Rüde, E., & Germann, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240403 · Cited by 287
Selection of a human T helper type 1-like T cell subset by mycobacteria.
Haanen, J. B., de Waal Malefijt, R., Res, P. C., Kraakman, E. M., Ottenhoff, T. H., de Vries, R. R., & Spits, H. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.583 · Cited by 279
Role of Cytokines in the Differentiation of CD4+ T‐Cell Subsets in vivo
Coffman, R. L., Varkila, K., Scott, P., & Chatelain, R. (1991) · Immunological Reviews · doi:10.1111/j.1600-065x.1991.tb00611.x · Cited by 277
Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function
Locksley, R. M., & Scott, P. (1991) · Immunology Today · doi:10.1016/s0167-5699(05)80017-9 · Cited by 276
IL-4-deficient Balb/c mice resist infection with Leishmania major.
Kopf, M., Brombacher, F., Köhler, G., Kienzle, G., Widmann, K. H., Lefrang, K., Humborg, C., Ledermann, B., & Solbach, W. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1127 · Cited by 273
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice
Locksley, R., Reiner, S., Hatam, F., Littman, D., & Killeen, N. (1993) · Science · doi:10.1126/science.8367726 · Cited by 268
Green, S. J., Nacy, C. A., & Meltzer, M. S. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.50.1.93 · Cited by 265
Self-citation
Metadata
- Authors
- Belosevic, M., Finbloom, D. S., Van Der Meide, P. H., Slayter, M. V., & Nacy, C. A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1989-07-01
- Volume
- 143
- Issue
- 1
- Pages
- 266-274
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1567366168
- Cited by
- 370
- References
- 0
- FWCI
- 25.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.